Processa Pharmaceuticals, Inc. financial data

Symbol
PCSA on Nasdaq
Location
Vero Beach, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 292% % -53%
Debt-to-equity 39% % 96%
Return On Equity -301% % -54%
Return On Assets -217% % -33%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 56,644,223 shares 1634%
Common Stock, Shares, Outstanding 52,862,926 shares 1518%
Entity Public Float $5,800,000 USD -43%
Common Stock, Value, Issued $5,287 USD 1517%
Weighted Average Number of Shares Outstanding, Basic 47,525,522 shares 1351%
Weighted Average Number of Shares Outstanding, Diluted 47,525,522 shares 1351%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense $5,611,768 USD 15%
Operating Income (Loss) $13,021,347 USD -10%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $3,010,326 USD -15%
Net Income (Loss) Attributable to Parent $12,933,604 USD -12%
Earnings Per Share, Basic -1 USD/shares 71%
Earnings Per Share, Diluted -1 USD/shares 71%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $6,308,420 USD 118%
Assets, Current $6,586,762 USD 36%
Property, Plant and Equipment, Net $4,113 USD -23%
Operating Lease, Right-of-Use Asset $24,318 USD
Assets $7,584,576 USD 53%
Accounts Payable, Current $727,172 USD 2.2%
Accrued Liabilities, Current $1,023,806 USD 148%
Liabilities, Current $1,750,978 USD 44%
Operating Lease, Liability, Noncurrent $21,831 USD -80%
Liabilities $1,750,978 USD 43%
Retained Earnings (Accumulated Deficit) $97,424,095 USD -15%
Stockholders' Equity Attributable to Parent $5,833,598 USD 57%
Liabilities and Equity $7,584,576 USD 53%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,729,848 USD -33%
Net Cash Provided by (Used in) Financing Activities $4,435,595 USD -29%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 52,867,926 shares 1516%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,705,747 USD -60%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,880 USD
Deferred Tax Assets, Valuation Allowance $19,902,665 USD 13%
Deferred Tax Assets, Gross $19,902,665 USD 13%
Operating Lease, Liability $21,832 USD -80%
Depreciation $301 USD 117%
Lessee, Operating Lease, Liability, to be Paid $23,347 USD -80%
Operating Lease, Liability, Current $21,832 USD -75%
Lessee, Operating Lease, Liability, to be Paid, Year One $70,040 USD -24%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,515 USD -77%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,000,000 shares
Unrecognized Tax Benefits $0 USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $889,054 USD 97%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares